CAS:201004-29-7 | FMOC-LYS(ME3)-OH HCL

Introduction of CAS:201004-29-7 | FMOC-LYS(ME3)-OH HCL

Supramolecular Gels : Fmoc-Lys(Fmoc)-OH is used in the creation of supramolecular hydrogels, which have applications in the biomedical field due to their biocompatible and biodegradable properties. These gels show antimicrobial activity, and their effectiveness can be enhanced with silver mixtures.

Polypeptide Synthesis : Fmoc-Lys(Boc)-OH is used for synthesizing polypeptides, which could provide new methods for disease prevention and treatment. The synthesis process aims to improve efficiency and yield.

Specification of CAS:201004-29-7 | FMOC-LYS(ME3)-OH HCL

Research Application of CAS:201004-29-7 | FMOC-LYS(ME3)-OH HCL

Organogelators : Fmoc and Boc mono-substituted cyclo(L-Lys-L-Lys)s serve as organogelators, forming stable thermo-reversible organogels in various solvents. These materials self-assemble into nanofiber, nanoribbon, or nanotube network structures, which have potential applications in nanotechnology (Zong et al., 2016).

Peptide Ligation : Azido-protected Fmoc–Lys–OH is synthesized and used in peptide ligation, a process important in the synthesis of various biomolecules (Katayama et al., 2008).

Ultrasound-induced Gelation : Fmoc-Lys(Fmoc)-OH and its derivatives can gelate various alcohols and aromatic solvents under sonication, displaying low minimum gelation concentrations. This property is significant for the development of novel materials and drug delivery systems (Geng et al., 2017).

Lipidomics : Fmoc chloride is used in the analysis of ethanolamine glycerophospholipid (PE) and lysoPE molecular species, enhancing the sensitivity and identification in mass spectrometry, which is crucial for understanding complex lipidomes (Han et al., 2005).

Antimicrobial Peptides : Fmoc groups are used in the synthesis of antimicrobial peptides, which have potential applications in treating infections (Liakopoulou-Kyriakides et al., 1997).

Insulin Analogs Synthesis : Fmoc-Lys(Pac)-OH is utilized in the preparation of novel semisynthetic insulin analogs, an important advancement in diabetes treatment (Žáková et al., 2007).

Hot Tags: cas:201004-29-7 | fmoc-lys(me3)-oh hcl, China cas:201004-29-7 | fmoc-lys(me3)-oh hcl manufacturers, factory, 3 Bromo 2 2 bis bromomethyl propanol, Beef extract, Methyltin mercaptide, 4 7 10 TRIOXA 1 13 TRIDECANEDIAMINE, 1 H Methylbenzotriazole Tolyltriazole, ISOSTEARIC ACID